The Ethical Treatment of Depression: Autonomy through Psychotherapy

Index

Action-readiness. See Emotion, and action-readiness ADM. See Antidepressant medication Affect biased, 60, 61 and decision-making, 4–5, 49–54, 63 and evaluative conditioning, 53 evaluative utility of, 39, 58–59 as evidence for the existence of triggering events, 4, 40, 41–44, 54 as evidence for the value of triggering events, 4, 40, 44–46, 54 evidential value of, 5, 39, 54–64 evidential value in depression, 5, 54, 94 heuristic, 53, 54 and the materiality of triggering events, 4, 39–46, 62–64 (see also Material facts) and motivation, 46–49, 54, 63 Agency, 10, 12–13 authorization condition for, 18 Allen, Nicholas, 105 Amygdala, 44, 52, 116, 117, 128, 131 Andersen, Susan, 67 Angermeyer, Matthias, 84 Antidepressant medication (ADM) and autonomy promotion in depression. See Autonomy, promotion with antidepressant medication (ADM) Index and beliefs about depression causation, 89–90 cognitive neuropsychological model of action, 111, 116 direct to consumer advertising (DTCA) of, 7, 88, 165–166 efficacy in depression, 3, 153 mode of action in depression, addressing information processing biases, 109–111 mode of action in depression, addressing stressors, 127–130 and restricted affective range in depression, 6, 113–117 and treatment statistics in depression, 1–2, 87 Antonuccio, David, 161 Australian Pharmaceutical Benefits Scheme, 87 Autonomy and the best interests of patients, 22, 31, 32 and chronic disease self-management. See Chronic disease self-management dispositional, 12 and the evidential value of affect, 54–64 and grounds for belief, 16 impairment in depression, the role of information processing biases, 74–77 and justified beliefs, 15–23 208 Index and justified beliefs about depressogenic stressors, 3, 82–95 and justified beliefs about the evidential value of affect, 54–64, 75–77 and material facts, 4, 20–21 and the materiality of depressogenic stressors, 82–85 normative force of, 4, 35–37, 146 occurrent, 11–12 and a particular patient standard of understanding, 20 and personhood, 37 and the physician’s duty of beneficence, 146, 147, 157 physician’s duty to promote in depression, 143–155 and the problem of authority, 11 professional, 7, 158–160 promotion through cognitive behavioral therapy (CBT), 3, 107–109, 111–118, 124–127, 130–141 promotion with antidepressant medication (ADM), 111–118, 130–141 as a proper goal of medicine. See Proper goals of medicine and rational assessment of beliefs, 14 respect for, versus promotion of, 157–158 summary statements of, 3–4, 13, 23, 131 and testimony, 17 theories of, epistemic, 4, 15–18 theories of, hierarchical, 3, 10–11, 13, 19 theories of, historical, 3, 11, 12, 19 theories of, life-plan, 3, 11–12, 13, 19 theories of, reasons-responsive, 3, 12, 13, 19 and true beliefs, 15–16 value of, instrumental, 4, 30–32, 146 value of, intrinsic, 4, 33–35, 146 Baird, Grayson, 86 Ball, Harriet, 92 Bayles, Michael, 158, 159 BDNF. See Brain derived neurotrophic factor Beauchamp, Tom, 17, 20, 21, 62, 133, 134 Beck, Aaron, 67, 109 Beecher, Henry, 31, 32 Beliefs. See Autonomy Beneficence, 7, 143, 159, 160, 162–164 duty of, 146, 147, 151 Beneficent authoritarianism, 24 Benson, John, 17, 57 Bentz, Bret, 102 Berlin, Isaiah, 10 Berofsky, Bernard, 13–14 Best interests. See also Prudential value and autonomy, 22, 31–32 and duty of care, 147, 162, 163 and informed consent, 31 and medical paternalism, 24 and refusal of medical treatment, 34 Beyondblue guidelines for treatment of depression in primary care, 3, 165. See also Depression, guidelines for treatment of Blumner, Kate, 85 Brain derived neurotrophic factor (BDNF), 80, 109 Brandt, Richard, 33 Brock, Dan, 26, 27, 28 Brown, Charlotte, 85 Brown, George, 79 Buchanan, Allen, 25, 26, 27, 28 Buss, Sarah, 18 Callahan, Daniel, 155 Campbell, Lynlee, 70 Autonomy (cont.) Index 209 Care, duty of, 147, 148, 150, 162, 163 Carson, Richard, 73 Caspi, Avshalom, 81 CBSM. See Cognitive behavioral stress management CBT. See Cognitive behavioral therapy Christman, John, 11, 12, 19 Chronic disease self-management, 7, 143, 149 Clore, Gerald, 54–55, 57 Cognitive behavioral stress management (CBSM), 120, 140 Cognitive behavioral therapy (CBT) and autonomy promotion in depression. See Autonomy, promotion through cognitive behavioral therapy (CBT) behavioral component of, 68, 106–107 collaborative empiricism in, 100, 112, 127 cost of, 160–161 debiasing in, 6, 99–105, duration of treatment, 90 efficacy in depression, 2, 67, 153 and metacognitive awareness, 77, 105–107 mindfulness approach in, 77, 105–107, 126 mode of action in depression...